We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc.

Product sales for the vaccine specialist Valneva reached €170m despite slow US sales of its chikungunya vaccine.

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Total revenue increased by 32% to CHF 209m Operating profit tripled to CHF 61mOperating cash flow significantly increased to CHF 74mAd hoc ...

Total revenue increased by 32% to CHF 209m Operating profit tripled to CHF 61mOperating cash flow significantly increased to CHF 74m Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023) Strong year-end cash position of €168.3 million; Substantial clinical and regulatory p ...

Interpublic Group of Companies (NYSE:IPG), a global provider of marketing solutions, finds itself at a crossroads as it navigates challenges in organic growth while pursuing strategic initiatives to ...

In the Q4 earnings call, the company stated that it has focused its R&D portfolio on four key therapeutic areas: oncology, ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...